The Hungarian Society of Experimental and Clinical Pharmacology announces its “Medicine of the Year 2023” award application The Hungarian Society of Experimental and Clinical Pharmacology (MFT) established the “Drug of the Year” award in 1996. The prize is the creation of Tamás Asszonyi, an artist from Szentendre: a large bronze relief and an accompanying certificate. Tovább …

Awarded medicine Pharmaceutical company VYDURA (rimegepant) Pfizer (2023) FORXIGA (dapagliflozin) AstraZeneca (2022) Venclyxto (venetoklax) AbbVie Kft. (2021) Prevymis (letermovir) MSD Pharma Hungary Kft. (2020) Reagila (cariprazine) Richter Gedeon Nyrt. (2019) Entresto (szakubitril/valzartán) Novartis Hungária Kft. (2018) Imbruvica (ibrutinib) Janssen-Cilag Kft. (2018) Keytruda (pembrolizumab) MSD Pharma Hungary Kft (2017) Jardiance (empagliflozin) Boehringer Ingelheim (2016) Valdoxan (agomelatin) Tovább …

The Hungarian Society of Experimental and Clinical Pharmacology announces its “Medicine of the Year 2023” award application The Hungarian Society of Experimental and Clinical Pharmacology (MFT) established the “Drug of the Year” award in 1996. The prize is the creation of Tamás Asszonyi, an artist from Szentendre: a large bronze relief and an accompanying certificate. Tovább …